Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

High serum C3 complement levels were associated with poor prognosis of angioimmunoblastic T-cell lymphoma (AITL)

Mengmeng Dong, Yi Zhong, Fang Yu, Yi Zhao, Lixia Zhu, Fengping Zhou, Linlin Huang, Xiu-Jin Ye, Zhen Cai, He Huang, Jin Zhang, Baodong Ye, Qingming Wang, Jingsong He

Blood (2025) 146 (Supplement 1): 7158.

https://doi.org/10.1182/blood-2025-7158

Published: 2025

Journal Articles

Adult hemophagocytic lymphohistiocytosis: A multicenter retrospective analysis of etiology and impact on survival in China

Jingsong He, Lixia Zhu, Mengqi Xiong, Jianguo Zhang, Yinyi Zhang, Xin Guo, Linjie Li, Lihong Shou, Qunyi Guo, Shuangwei Ying, Li Li, YI LI, Zhen Cai, He Huang, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 6549.

https://doi.org/10.1182/blood-2025-6549

Published: 2025

Journal Articles

A phase 2 dose confirmation trial of oral ASTX030, a combination of oral azacitidine with cedazuridine among patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

Guillermo Garcia-Manero, Uma Borate, Andrew Brunner, Bonnie Kiner-Strachan, Bart Scott, Yazan Madanat, Michael Savona, Elizabeth Griffiths, Aram Oganesian, Yuri Sano, Lixia Zhu, Gareth Tomlinson, Danna Chan, Harold Keer, James McCloskey

Blood (2025) 146 (Supplement 1): 491.

https://doi.org/10.1182/blood-2025-491

Published: 2025

Journal Articles

Efficacy and safety of azacitidine plus LDAC in newly diagnosed, frail elderly patients with Acute Myeloid Leukemia

Lixia Zhu, Li Li, Xin Guo, Gaofeng Zheng, Yi Li, Jingsong He, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 6983.

https://doi.org/10.1182/blood-2025-6983

Published: 2025

Journal Articles

Elevated interleukin-10 at diagnosis and during treatment independently predicts adverse outcomes in angioimmunoblastic T-cell lymphoma

Yi Zhong, Mengmeng Dong, Fang Yu, Yi Zhao, Lixia Zhu, Fengping Zhou, Wenjun Wu, Yi Li, Fangshu Guan, Linlin Huang, Xiu-Jin Ye, Zhen Cai, Jin Zhang, Baodong Ye, Qingming Wang, Jingsong He

Blood (2025) 146 (Supplement 1): 3645.

https://doi.org/10.1182/blood-2025-3645

Published: 2025

Journal Articles

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

Yanmin Zhao, Yeqian Zhao, Shanshan Pei, Jimin Shi, Yi Luo, Jie Sun, Weiyan Zheng, Wenjun Wu, Yi Zhao, Lixia Zhu, Jian Yu, Lizhen Liu, Xiaoyu Lai, Huarui Fu, He Huang, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 3404.

https://doi.org/10.1182/blood-2025-3404

Published: 2025

Journal Articles

The addition of EBV and C3 complement risk factors formed a better angioimmunoblastic T-cell lymphoma prognostic scoring system

Mengmeng Dong, Yi Zhong, Fang Yu, Yi Zhao, Lixia Zhu, Fengping Zhou, Linlin Huang, Xiu-Jin Ye, Zhen Cai, He Huang, Jin Zhang, Baodong Ye, Qingming Wang, Jingsong He

Blood (2025) 146 (Supplement 1): 7148.

https://doi.org/10.1182/blood-2025-7148

Published: 2025

Journal Articles

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Jia Hu, Jingyi Huang, Wei Bian, Xiaoqing Zou, Yuanyuan Zhu, Weijia Huang, Yue Liang, Yi Zhao, Weiyan Zheng, Lixia Zhu, Xiu-Jin Ye, Yi Luo, Jimin Shi, Zhen Cai, He Huang, Shanshan Pei, Jie Sun

Blood (2025) 146 (Supplement 1): 1508.

https://doi.org/10.1182/blood-2025-1508

Published: 2025

Journal Articles

Inotuzumab ozogamicin as salvage therapy for refractory/relapsed B-cell acute lymphoblastic leukemia following the failure of chimeric antigen receptor T cell therapy and allogeneic hematopoietic stem cell transplantation

Honghu Li, Luxin Yang, Lizhen Liu, Xiaoyu Lai, Lixia Zhu, Kui zhao, He Huang, Yi Luo

Blood (2025) 146 (Supplement 1): 7810.

https://doi.org/10.1182/blood-2025-7810

Published: 2025

Journal Articles

Involvement of bone marrow, liver, spleen and extranodal number were associated with poor outcome in angioimmunoblastic T-cell lymphoma (AITL) patients

Mengmeng Dong, Yi Zhong, Fang Yu, Yi Zhao, Lixia Zhu, Fengping Zhou, Linlin Huang, Xiu-Jin Ye, Zhen Cai, He Huang, Jin Zhang, Baodong Ye, Qingming Wang, Jingsong He

Blood (2025) 146 (Supplement 1): 7169.

https://doi.org/10.1182/blood-2025-7169

Published: 2025

Journal Articles

Quantitative 18F-FDG-PET/CT analysis of splenic suvmax enhances diagnostic accuracy in primary splenic non-Hodgkin lymphoma

Li li, Mengqi Xiong, Lu-Lu Wang, Lixia zhu, Kui zhao, lijun wang, Jingsong He, Xiu-Jin Ye

Blood (2025) 146 (Supplement 1): 3607.

https://doi.org/10.1182/blood-2025-3607

Published: 2025

Journal Articles

Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China

De Zhou, Xianbo Huang, Lixia Zhu, Xuelian Hu, Xiudi Yang, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Jingjing Zhu, Shuqi Zhao, Wanzhuo Xie, Hongyan Tong, Jie Jin, Xiujin Ye

Blood (2025) 146 (3): 318–327.

https://doi.org/10.1182/blood.2024026139

Published: 2025

Includes: Supplemental data

Journal Articles

Results from a Phase 1 Open-Label Dose Escalation and Expansion Trial of Oral Azacitidine + Cedazuridine (ASTX030) in Patients with Myelodysplastic Syndromes (MDS) and MDS/Myeloproliferative Neoplasms (MPN)

Guillermo Garcia-Manero, James McCloskey, Bart L. Scott, Elizabeth A. Griffiths, Bonnie Kiner-Strachan, Andrew M. Brunner, Amer M. Zeidan, Elie Traer, Yazan F. Madanat, Janelle Meyer, Harry Erba, Praneeth Baratam, Uma Borate, Yuri Sano, Aram Oganesian, Lixia Zhu, Harold N. Keer, Michael R. Savona

Blood (2024) 144 (Supplement 1): 662.

https://doi.org/10.1182/blood-2024-203569

Published: 2024

Journal Articles

A Respective Analysis of EBV DNA Status in T/NK Cell Lymphoma Associated-Hemophagocytic Lymphohistiocytosis

Li Li, Mengqi Xiong, Lulu Wang, Lixia Zhu, Rongrong Chen, Jingsong He, Xiu-Jin Ye

Blood (2023) 142 (Supplement 1): 1176.

https://doi.org/10.1182/blood-2023-178471

Published: 2023

Journal Articles

Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial

De Zhou, Xianbo Huang, Xueying Li, Lixia Zhu, Mixue Xie, Xin Huang, Fang Yu, Juying Wei, Liya Ma, Xiudi Yang, Jianai Sun, Li Li, Wanzhuo Xie, Hongyan Tong, Jie Jin, Honghu Zhu, Xiujin Ye

Blood (2022) 140 (Supplement 1): 2620–2621.

https://doi.org/10.1182/blood-2022-164496

Published: 2022

Journal Articles

A Phase 1 Study Evaluating ASTX727 (decitabine and cedazuridine) and Venetoclax Combination Therapy in Newly Diagnosed AML Patients Unfit for Intensive Induction Chemotherapy

Gabriel N. Mannis, Elizabeth A. Griffiths, Michael R. Savona, Olatoyosi Odenike, Gail J. Roboz, Casey L. O'Connell, Jacqueline Dillingham, Prieya Wason, Lixia Zhu, Danna Chan, Harold N. Keer, Aram Oganesian, Kim-Hien Dao, Courtney D. DiNardo

Blood (2021) 138 (Supplement 1): 1245.

https://doi.org/10.1182/blood-2021-146264

Published: 2021

Journal Articles

Differentiated Expression of microRNAs May be Regulated By the Vascular Endothelial Growth Factor in Acute Myeloid Leukemia

Xiujin Ye, Lixia Zhu

Blood (2014) 124 (21): 5322.

https://doi.org/10.1182/blood.V124.21.5322.5322

Published: 2014

Journal Articles

Analysis of the Clinical Features and the Prognosis of Acute Lymphoblastic Leukemia with Complex Chromosomal Aberrations

Xiujin Ye, Lixia Zhu, Li Li, Jie Zhang, Jingsong He, Jingjing Zhu, He Huang, Zhen Cai

Blood (2011) 118 (21): 4914.

https://doi.org/10.1182/blood.V118.21.4914.4914

Published: 2011

Journal Articles

Predictive Factors of Response and Survival Following Chemotherapy Treatment In Acute Leukemia with Complex Karyotype Aberrations

Xiujin Ye, Lixia Zhu, Chunyuan He, Jinjin Zhu, Li Li, Jingsong He, Jie Zhang, He Huang, MD, PhD, Zhen Cai

Blood (2010) 116 (21): 4857.

https://doi.org/10.1182/blood.V116.21.4857.4857

Published: 2010

Journal Articles

Myeloid Sarcoma: a Clinical Report of 18 Cases

Xiujin Ye, Lixia Zhu, Jinjin Zhu, Li Li, Jingsong He, Jie Zhang, He Huang, MD, PhD and Zhen Cai

Blood (2010) 116 (21): 4377.

https://doi.org/10.1182/blood.V116.21.4377.4377

Published: 2010

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

High serum C3 complement levels were associated with poor prognosis of angioimmunoblastic T-cell lymphoma (AITL)

Adult hemophagocytic lymphohistiocytosis: A multicenter retrospective analysis of etiology and impact on survival in China

A phase 2 dose confirmation trial of oral ASTX030, a combination of oral azacitidine with cedazuridine among patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

Efficacy and safety of azacitidine plus LDAC in newly diagnosed, frail elderly patients with Acute Myeloid Leukemia

Elevated interleukin-10 at diagnosis and during treatment independently predicts adverse outcomes in angioimmunoblastic T-cell lymphoma

Genetic risk stratification in adults with AML receiving venetoclax-based intensive therapy: A real-world study

The addition of EBV and C3 complement risk factors formed a better angioimmunoblastic T-cell lymphoma prognostic scoring system

Disrupting monocytic AML and monocytic leukemia stem cells with a novel cladribine regimen: From bench to bedside

Inotuzumab ozogamicin as salvage therapy for refractory/relapsed B-cell acute lymphoblastic leukemia following the failure of chimeric antigen receptor T cell therapy and allogeneic hematopoietic stem cell transplantation

Involvement of bone marrow, liver, spleen and extranodal number were associated with poor outcome in angioimmunoblastic T-cell lymphoma (AITL) patients

Quantitative 18F-FDG-PET/CT analysis of splenic suvmax enhances diagnostic accuracy in primary splenic non-Hodgkin lymphoma

Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China

Results from a Phase 1 Open-Label Dose Escalation and Expansion Trial of Oral Azacitidine + Cedazuridine (ASTX030) in Patients with Myelodysplastic Syndromes (MDS) and MDS/Myeloproliferative Neoplasms (MPN)

A Respective Analysis of EBV DNA Status in T/NK Cell Lymphoma Associated-Hemophagocytic Lymphohistiocytosis

Ruxolitinib Combined with Dexamethasone in Adult Patients with Newly Diagnosed Hemophagocytic Lymphohistiocytosis: A Prospective, Single-Center, Single-Arm, Phase 2 Clinical Trial

A Phase 1 Study Evaluating ASTX727 (decitabine and cedazuridine) and Venetoclax Combination Therapy in Newly Diagnosed AML Patients Unfit for Intensive Induction Chemotherapy

Differentiated Expression of microRNAs May be Regulated By the Vascular Endothelial Growth Factor in Acute Myeloid Leukemia

Analysis of the Clinical Features and the Prognosis of Acute Lymphoblastic Leukemia with Complex Chromosomal Aberrations

Predictive Factors of Response and Survival Following Chemotherapy Treatment In Acute Leukemia with Complex Karyotype Aberrations

Myeloid Sarcoma: a Clinical Report of 18 Cases

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only